IndraLab

Statements



reach
"We provide evidence that the known EAG2 channel blocker astemizole reduces MB cell migratory polarization and cell rear contraction, and impairs MB cell viability, motility and allografted tumor growth (XREF_FIG and XREF_SUPPLEMENTARY)."